Innate Pharma S.A. (FRA:IDDA)
Germany · Delayed Price · Currency is EUR 1.560
+0.020 (1.30%)
At close: Dec 19, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €141.38 million as of December 19, 2025. Its market cap has increased by 6.74% in one year.
Market Cap
141.38M
Enterprise Value
108.39M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.56
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 141.38M, an increase of 17,748.81%. That is a compound annual growth rate of 31.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 141.38M | -11.60% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | 273.37M | -41.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |